On 29 April 2026, the World Health Organization certified Australia as the 30th country to eliminate trachoma as a public health problem. Trachoma is the world's leading infectious cause of blindness: infection with the bacterium Chlamydia trachomatis leads, after repeated exposure, to scarring under the eyelids that gradually turns inward until the lashes scrape the cornea and permanently damage vision. In most wealthy countries, trachoma disappeared long ago with improvements in hygiene and housing. In Australia, it persisted exclusively in indigenous and Torres Strait Islander communities in remote Outback regions.
Structural Inequality as the Root Cause
That trachoma still existed in Australia was not a medical anomaly but a symptom. The disease spreads where drinking water is scarce, sanitation is poor and housing is overcrowded. It never affected wealthy white Australians at any point in the country's modern history. It was a disease of poverty and of the history of dispossession and structural neglect that continues to shape life in many remote indigenous communities.
Australia launched the National Trachoma Management Program in 2006, following the WHO SAFE strategy: Surgery for advanced cases, Antibiotics with azithromycin, Facial cleanliness for children, and Environmental improvement covering water and sanitation. The WHO explicitly stated in its announcement that Aboriginal Community Controlled Health Organisations, health bodies led by indigenous communities themselves, drove the program's implementation. Without their leadership, the WHO noted, the outcome could not have been achieved.
Where Similar Successes Have Been Achieved
Australia is the 30th country to eliminate trachoma and the 63rd overall to have eliminated at least one so-called neglected tropical disease (NTD). For comparison: Morocco declared trachoma eliminated in 2019 after a decade of mass treatment campaigns. Togo, one of the first West African countries to reach the WHO threshold, achieved it in 2020 with a program that treated up to eight million people annually with azithromycin between 2010 and 2019, while simultaneously building latrines and teaching facial hygiene in schools.
The Guinea worm offers an even more striking example of what sustained public health work can achieve: in 1986 it infected 3.5 million people per year; in 2025 only ten cases were registered worldwide. Chile, by contrast, declared leprosy eliminated only in 2026, becoming the first country in Latin America to do so, illustrating how slow such processes can be.
The common foundation of all these successes: neglected diseases do not require expensive therapies. They require persistence, community engagement and the political decision not to leave communities behind because they have no economic market power.
What the Certification Concretely Means
The WHO elimination threshold for trachoma is below five percent active trachoma in children aged one to nine, and below 0.2 percent trichiasis, meaning lashes touching the cornea, in the adult population. Australia has fallen below these thresholds nationwide and maintained control sustainably.
Globally, around 137 million people in 44 countries remain at risk from active trachoma, according to the WHO. The most severely affected countries are Ethiopia, Nigeria and the Democratic Republic of Congo. WHO-funded SAFE programs are running in all of them, many for more than a decade. Australia's certification confirms that the strategy works when implemented consistently.
From 2006 to 2026: What Two Decades Can Achieve
The Australian program took exactly 20 years. That sounds long, but is shorter than expected given that trachoma in some Outback areas had prevalence rates above 20 percent in children. The WHO also requires a minimum three-year observation period after falling below the threshold, to ensure that improvements are not temporary.
Whether Australia sustains this elimination in the long term depends on structural investment: drinking water, sewage and housing in remote indigenous communities remain politically contested areas. The WHO recommends maintaining surveillance programs. Trachoma can return if living conditions deteriorate again. That has happened in other countries after prematurely declared elimination. Australia knows this, and the indigenous health organisations that carried the program for two decades know it best of all.